PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
7.60%
Revenue growth above 1.5x TSM's 2.02%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
7.95%
Gross profit growth above 1.5x TSM's 5.04%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
11.19%
EBIT growth above 1.5x TSM's 4.61%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
11.19%
Operating income growth above 1.5x TSM's 4.61%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
21.88%
Positive net income growth while TSM is negative. John Neff might see a big relative performance advantage.
21.21%
EPS growth above 1.5x TSM's 5.36%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
23.71%
Diluted EPS growth above 1.5x TSM's 5.36%. David Dodd would see if there's a robust moat protecting these shareholder gains.
0.20%
Share count expansion well above TSM's 0.00%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.28%
Slight or no buyback while TSM is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
-0.20%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
99.67%
OCF growth above 1.5x TSM's 17.97%. David Dodd would confirm a clear edge in underlying cash generation.
112.63%
FCF growth above 1.5x TSM's 3.46%. David Dodd would verify if the firm’s strategic investments yield superior returns.
683.17%
10Y revenue/share CAGR above 1.5x TSM's 376.38%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
210.71%
5Y revenue/share CAGR above 1.5x TSM's 125.34%. David Dodd would look for consistent product or market expansions fueling outperformance.
237.21%
3Y revenue/share CAGR above 1.5x TSM's 97.19%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
621.63%
10Y OCF/share CAGR 1.25-1.5x TSM's 469.91%. Bruce Berkowitz would confirm if the firm's long-term capital allocation yields better cash returns.
271.61%
5Y OCF/share CAGR above 1.5x TSM's 138.53%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
228.58%
3Y OCF/share CAGR above 1.5x TSM's 139.91%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
2428.00%
Net income/share CAGR above 1.5x TSM's 554.90% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
305.01%
5Y net income/share CAGR above 1.5x TSM's 169.15%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
415.25%
3Y net income/share CAGR above 1.5x TSM's 134.68%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
526.98%
10Y equity/share CAGR above 1.5x TSM's 307.22%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
308.00%
5Y equity/share CAGR above 1.5x TSM's 97.21%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
177.13%
3Y equity/share CAGR above 1.5x TSM's 82.55%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
16.24%
Below 50% of TSM's 192733578.80%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
-0.73%
Negative near-term dividend growth while TSM invests at 37.51%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
17.60%
Our AR growth while TSM is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
16.66%
Inventory growth well above TSM's 1.29%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
8.75%
Asset growth 1.25-1.5x TSM's 6.92%. Bruce Berkowitz sees if the firm's investments effectively outpace the competitor in future returns.
11.60%
BV/share growth above 1.5x TSM's 7.56%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
No Data
No Data available this quarter, please select a different quarter.
4.49%
R&D growth drastically higher vs. TSM's 3.75%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
1.08%
SG&A declining or stable vs. TSM's 15.92%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.